CardioPET
CardioPET is:
- An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium
CardioPET may be used to:
- Identify patients that will benefit from PCI or revascularization and guide intervention
- Assess myocardial viability
- Evaluate CAD in patients that cannot exercise
